These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 9294616

  • 1. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
    Packham G, Cleveland JL.
    Oncogene; 1997 Sep 04; 15(10):1219-32. PubMed ID: 9294616
    [Abstract] [Full Text] [Related]

  • 2. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
    Peña A, Wu S, Hickok NJ, Soprano DR, Soprano KJ.
    J Cell Physiol; 1995 Feb 04; 162(2):234-45. PubMed ID: 7822433
    [Abstract] [Full Text] [Related]

  • 3. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.
    Tobias KE, Shor J, Kahana C.
    Oncogene; 1995 Nov 02; 11(9):1721-7. PubMed ID: 7478599
    [Abstract] [Full Text] [Related]

  • 4. Regulation of c-myc and ornithine decarboxylase expression by distinct protein kinase systems in IL-3-dependent myeloid cells.
    Farrar WL, Willette-Brown J, Linnekin D.
    Lymphokine Cytokine Res; 1991 Aug 02; 10(4):291-9. PubMed ID: 1718453
    [Abstract] [Full Text] [Related]

  • 5. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways.
    Packham G, Porter CW, Cleveland JL.
    Oncogene; 1996 Aug 01; 13(3):461-9. PubMed ID: 8760287
    [Abstract] [Full Text] [Related]

  • 6. hnRNP U interacts with the c-Myc-Max complex on the E-box promoter region inducing the ornithine decarboxylase gene.
    Matsuoka Y, Uehara N, Tsubura A.
    Oncol Rep; 2009 Aug 01; 22(2):249-55. PubMed ID: 19578763
    [Abstract] [Full Text] [Related]

  • 7. c-Myc induces the expression and activity of ornithine decarboxylase.
    Wagner AJ, Meyers C, Laimins LA, Hay N.
    Cell Growth Differ; 1993 Nov 01; 4(11):879-83. PubMed ID: 8297793
    [Abstract] [Full Text] [Related]

  • 8. Position and orientation independent transactivation by c-Myc.
    Packham G, Bello-Fernandez C, Cleveland JL.
    Cell Mol Biol Res; 1994 Nov 01; 40(7-8):699-706. PubMed ID: 7787888
    [Abstract] [Full Text] [Related]

  • 9. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D, Mader R, Lee J, Hurta RA.
    Biochem Cell Biol; 2001 Nov 01; 79(1):69-81. PubMed ID: 11235918
    [Abstract] [Full Text] [Related]

  • 10. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA, Lee J, Voskas D.
    J Cell Biochem; 2001 Nov 01; 81(1):39-55. PubMed ID: 11180396
    [Abstract] [Full Text] [Related]

  • 11. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
    Askew DS, Ashmun RA, Simmons BC, Cleveland JL.
    Oncogene; 1991 Oct 01; 6(10):1915-22. PubMed ID: 1923514
    [Abstract] [Full Text] [Related]

  • 12. APC-dependent regulation of ornithine decarboxylase in human colon tumor cells.
    Fultz KE, Gerner EW.
    Mol Carcinog; 2002 May 01; 34(1):10-8. PubMed ID: 12112318
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-7 regulates c-myc expression in murine T cells and thymocytes: a role for tyrosine kinase(s) and calcium mobilization.
    Seckinger P, Milili M, Schiff C, Fougereau M.
    Eur J Immunol; 1994 Mar 01; 24(3):716-22. PubMed ID: 7510242
    [Abstract] [Full Text] [Related]

  • 14. A role for protein kinase C-delta in the regulation of ornithine decarboxylase expression by oxidative stress.
    Otieno MA, Kensler TW.
    Cancer Res; 2000 Aug 15; 60(16):4391-6. PubMed ID: 10969783
    [Abstract] [Full Text] [Related]

  • 15. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP, Colburn NH, Verma AK.
    Oncogene; 1999 Oct 14; 18(42):5806-13. PubMed ID: 10523861
    [Abstract] [Full Text] [Related]

  • 16. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
    Lin CK, Zou HY, Kaptein JS, Yen CF, Kalunta CI, Nguyen TT, Park E, Lad PM.
    Exp Cell Res; 1997 Nov 25; 237(1):231-41. PubMed ID: 9417887
    [Abstract] [Full Text] [Related]

  • 17. Effect of Na + flux inhibitors on induction of c-fos, c-myc, and ODC genes during cell cycle.
    Panet R, Amir I, Snyder D, Zonenshein L, Atlan H, Laskov R, Panet A.
    J Cell Physiol; 1989 Jul 25; 140(1):161-8. PubMed ID: 2472417
    [Abstract] [Full Text] [Related]

  • 18. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, Nilsson LM, Neale G, Kramer DL, Porter CW, Cleveland JL.
    Cancer Cell; 2005 May 25; 7(5):433-44. PubMed ID: 15894264
    [Abstract] [Full Text] [Related]

  • 19. Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.
    Li RS, Law GL, Seifert RA, Romaniuk PJ, Morris DR.
    Exp Cell Res; 1999 Feb 25; 247(1):257-66. PubMed ID: 10047468
    [Abstract] [Full Text] [Related]

  • 20. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A, Millington M, Sun LQ, Symonds G.
    Cancer Gene Ther; 2000 Nov 25; 7(11):1491-503. PubMed ID: 11129291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.